(Q36461733)

14 August 2017

title

The current understanding of the molecular determinants of inflammatory breast cancer metastasis (English)

1 reference

inflammatory breast cancer

14 August 2017

main subject

1 reference

1 reference

Galina S Radunsky

1

1 reference

14 August 2017

Kenneth L van Golen

series ordinal

2

1 reference

14 August 2017

publication date

1 January 2005

1 reference

Clinical & Experimental Metastasis

14 August 2017

published in

1 reference

14 August 2017

volume

22

1 reference

14 August 2017

issue

8

1 reference

14 August 2017

page(s)

615-620

1 reference

WISP3 and RhoC guanosine triphosphatase cooperate in the development of inflammatory breast cancer

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10585-006-9000-7

Epithelial-mesenchymal transition: NF-kappaB takes center stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-006-9000-7

NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-006-9000-7

Inflammatory Carcinoma of the Breast in a 12-Year-Old Girl

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-006-9000-7

Correlation of KIT and EGFR overexpression with invasive ductal breast carcinoma of the solid-tubular subtype, nuclear grade 3, and mesenchymal or myoepithelial differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-006-9000-7

Prognosis of dermal lymphatic invasion with or without clinical signs of inflammatory breast cancer.

21 January 2018

1 reference

12 December 2020

A novel human xenograft model of inflammatory breast cancer.

1 reference

12 December 2020

The use of steroïd hormone receptors in the treatment of human breast cancer: a review

1 reference

12 December 2020

Strong association between c-myb and oestrogen-receptor expression in human breast cancer.

1 reference

12 December 2020

Persistent E-cadherin expression in inflammatory breast cancer

1 reference

12 December 2020

Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells

1 reference

12 December 2020

Gene expression profiling identifies molecular subtypes of inflammatory breast cancer

1 reference

12 December 2020

Molecular requirements for epithelial-mesenchymal transition during tumor progression

1 reference

12 December 2020

Update on inflammatory breast cancer

1 reference

12 December 2020

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

1 reference

12 December 2020

WISP3 is a novel tumor suppressor gene of inflammatory breast cancer

1 reference

12 December 2020

RhoC induces differential expression of genes involved in invasion and metastasis in MCF10A breast cells

1 reference

12 December 2020

Caveolin-1 inhibits epidermal growth factor-stimulated lamellipod extension and cell migration in metastatic mammary adenocarcinoma cells (MTLn3). Transformation suppressor effects of adenovirus-mediated gene delivery of caveolin-1.

1 reference

12 December 2020

Molecular portraits of human breast tumours

1 reference

12 December 2020

Cadherin switch in tumor progression

1 reference

12 December 2020

Inflammatory Breast Cancer Survival: The Role of Obesity and Menopausal Status at Diagnosis

1 reference

12 December 2020

Repeated observation of breast tumor subtypes in independent gene expression data sets

1 reference

12 December 2020

Inflammatory breast cancer shows angiogenesis with high endothelial proliferation rate and strong E-cadherin expression

1 reference

12 December 2020

Cadherins and the tumour progression: is it all in a switch?

1 reference

12 December 2020

Distinct molecular signature of inflammatory breast cancer by cDNA microarray analysis.

1 reference

12 December 2020

Breast cancer in women under 30 years of age.

1 reference

12 December 2020

Inflammatory breast cancer: the experience of the surveillance, epidemiology, and end results (SEER) program

1 reference

12 December 2020

Gene Expression Profiling for Molecular Characterization of Inflammatory Breast Cancer and Prediction of Response to Chemotherapy

1 reference

12 December 2020

N-cadherin expression in breast cancer: correlation with an aggressive histologic variant--invasive micropapillary carcinoma

1 reference

12 December 2020

Invasion activating caveolin-1 mutation in human scirrhous breast cancers.

1 reference

12 December 2020

Update on the management of inflammatory breast cancer

1 reference

12 December 2020

Cell kinetics and hormonal receptor status in inflammatory breast carcinoma. Comparison with locally advanced disease.

1 reference

12 December 2020

Validation of a tissue microarray to study differential protein expression in inflammatory and non-inflammatory breast cancer

1 reference

12 December 2020

An intact overexpressed E-cadherin/alpha,beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma

1 reference

12 December 2020

Steroid hormone receptors in the management of human breast cancer.

1 reference

12 December 2020

Molecular biology of breast cancer metastasis. Inflammatory breast cancer: clinical syndrome and molecular determinants

1 reference

12 December 2020

Tetrathiomolybdate inhibits angiogenesis and metastasis through suppression of the NFkappaB signaling cascade.

1 reference

12 December 2020

Regulation of pancreatic cancer cell migration and invasion by RhoC GTPase and caveolin-1

1 reference

12 December 2020

Are risk factors for breast cancer similar in women with inflammatory breast cancer and in those with non-inflammatory breast cancer?

1 reference

12 December 2020

Caveolin-1 inhibits breast cancer growth and metastasis

1 reference

12 December 2020

p53 mutations and overexpression in locally advanced breast cancers

1 reference

12 December 2020

Inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program of the National Cancer Institute, 1975-1992.

1 reference

12 December 2020

Breast conservation and prolonged chemotherapy for locally advanced breast cancer: the University of Michigan experience

1 reference

12 December 2020

Nuclear factor-kappaB: the enemy within

1 reference

12 December 2020

The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene

1 reference

12 December 2020

Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells

1 reference

12 December 2020

A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype.

1 reference

12 December 2020

Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer

1 reference

12 December 2020

Inflammatory breast cancer and body mass index

1 reference

12 December 2020

Inflammatory breast cancer: a review

1 reference

12 December 2020

RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype.

1 reference

12 December 2020

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 reference

12 December 2020

RhoC GTPase overexpression modulates induction of angiogenic factors in breast cells

1 reference

12 December 2020

Inflammatory carcinoma of the breast. Clinical review and summary of the Vanderbilt experience with multi-modality therapy

1 reference

12 December 2020

10.1007/S10585-006-9000-7

Identifiers

DOI

1 reference

14 August 2017

1 reference